Advancing the Sustainable Use of Ethylene Oxide through Process Validation.
Based on excellent material compatibility and ability for scale, ethylene oxide (EO) sterilization constitutes approximately 50% of single-use medical device sterilization globally. Epidemiological considerations have elevated focus toward optimization of EO processes, whereby only necessary amounts...
| Published in: | Biomedical Instrumentation & Technology Vol. 55; no. S3; pp. 35 - 45 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Published: |
Association for the Advancement of Medical Instrumentation (AAMI)
2021Supplement
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150674935&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 150674935 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08998205 FZO jtl: Biomedical Instrumentation & Technology issn: 08998205 maglogo: N pubinfo: dt: 2021Supplement vid: 55 iid: S3 pid: 13730 pub: Association for the Advancement of Medical Instrumentation (AAMI) place: Arlington, Virginia artinfo: ui: 150674935 150674935 NLM34153998 10.2345/0899-8205-55.s3.35 NLM34153998 150674935 ppf: 35 ppct: 10 formats: tig: atl: Advancing the Sustainable Use of Ethylene Oxide through Process Validation. aug: au: McEvoy, Brian Wiehle, Stacy Bohl Gordon, Ken Kearns, Gerry Laranjeira, Paulo McLees, Nicole sug: subj: Ethylene Oxide Sterilization and Disinfection Industry ab: Based on excellent material compatibility and ability for scale, ethylene oxide (EO) sterilization constitutes approximately 50% of single-use medical device sterilization globally. Epidemiological considerations have elevated focus toward optimization of EO processes, whereby only necessary amounts of sterilant are used in routine processing. EO sterilization of medical devices is validated in accordance with AAMI/ANSI/ISO 11135:2014 via a manner in which a sterility assurance level (SAL) of 10-6 is typically achieved, with multiple layers of conservativeness delivered, using "overkill" approaches to validation. Various optimization strategies are being used throughout the medical device industry to deliver the required SAL while utilizing only necessary amounts of sterilant. This article presents relevant experiences and describes challenges and considerations encountered in delivering EO process optimization. Thus far, the results observed by the authors are encouraging in demonstrating how EO processing can be optimized in the delivery of critical single-use medical devices for patient care. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|